✦ LIBER ✦

Clinical utility and outcome of HFE-genotyping in the search for hereditary hemochromatosis

✍ Scribed by Jokke Hannuksela; Onni Niemelä; Mari Leppilampi; Anna-Kaisa Parkkila; Pirjo Koistinen; Pentti Nieminen; Seppo Parkkila

Book ID: 117074908
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 134 KB
Volume: 331
Category: Article
ISSN: 0009-8981
DOI: 10.1016/s0009-8981(03)00087-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hemochromatosis gene (HFE) mutations and

Hemochromatosis gene (HFE) mutations and cancer risk: Expanding the clinical manifestations of hereditary iron overload

✍ Silvia Fargion; Luca Valenti; Anna Ludovica Fracanzani 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 253 KB 👁 1 views

HFE -associated hereditary hemochromatos

HFE -associated hereditary hemochromatosis: Overview of genetics and clinical implications for nurse practitioners in primary care settings

✍ Emanuele, Donna; Tuason, Ivy; Edwards, Quannetta T. 📂 Article 📅 2014 🏛 Ovid Technologies (Wolters Kluwer) - Lippincott W 🌐 English ⚖ 402 KB

Co-factors in liver disease: The role of

Co-factors in liver disease: The role of HFE-related hereditary hemochromatosis and iron

✍ Daniel F. Wallace; V. Nathan Subramaniam 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 315 KB

Mutation analysis of the HFE gene associ

Mutation analysis of the HFE gene associated with hereditary hemochromatosis in African Americans

✍ Monaghan, Kristin G.; Rybicki, Benjamin A.; Shurafa, Muhammad; Feldman, Gerald L 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 2 views

Homozygosity for the mutation Cys282Tyr in the HFE gene has recently been identified as a cause of hereditary hemochromatosis, a disorder resulting in the inappropriate absorption of iron. Approximately 10% of Caucasians are heterozygous for this mutation; however, the gene frequency in African Amer

Prevalence of the Cys282Tyr and His63Asp

Prevalence of the Cys282Tyr and His63Asp HFE gene mutations in Spanish patients with hereditary hemochromatosis and in controls

✍ Mayka Sánchez; Miquel Bruguera; Jaume Bosch; Joan Rodés; Francisca Ballesta; Raf 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 76 KB

A phase 1/2, dose-escalation trial of de

A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis

✍ Pradyumna Phatak; Pierre Brissot; Mark Wurster; Paul C Adams; Herbert L. Bonkovs 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 391 KB 👁 1 views

Hereditary hemochromatosis (HH) is characterized by increased intestinal iron absorption that may result in iron overload. Although phlebotomy is widely practiced, it is poorly tolerated or contraindicated in patients with anemias, severe heart disease, or poor venous access, and compliance can vary